Advertisement

Index by author

January 01, 1992; Volume 20,Issue 1

A

  1. Ackermann, B L

    1. Metabolism of the anticoagulant peptide, MDL 28,050, in rats.
      M P Knadler, B L Ackermann, J E Coutant and G H Hurst
      Drug Metabolism and Disposition January 1992, 20 (1) 89-95;

  2. Almirez, R

    1. Comparisons of hepatic and renal cytochromes P-450-dependent monooxygenases from fuzzy and Sprague-Dawley rats.
      E Cheriathundam, R Almirez and A P Alvares
      Drug Metabolism and Disposition January 1992, 20 (1) 19-22;

  3. Alvares, A P

    1. Comparisons of hepatic and renal cytochromes P-450-dependent monooxygenases from fuzzy and Sprague-Dawley rats.
      E Cheriathundam, R Almirez and A P Alvares
      Drug Metabolism and Disposition January 1992, 20 (1) 19-22;

  4. Aoki, K

    1. Deacetylation of cinobufagin by rat liver.
      L Zhang, K Aoki, T Yoshida and Y Kuroiwa
      Drug Metabolism and Disposition January 1992, 20 (1) 52-55;

B

  1. Ball, S E

    1. Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans.
      S E Ball, G Maurer, M Zollinger, M Ladona and A E Vickers
      Drug Metabolism and Disposition January 1992, 20 (1) 56-63;

  2. Ballantyne, B

    1. Pharmacokinetics of 2-ethyl-1,3-hexanediol. II. Nonsystemic disposition following single percutaneous or peroral doses in Fischer 344 rats.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant and B Ballantyne
      Drug Metabolism and Disposition January 1992, 20 (1) 6-18;

  3. Barnes, S

    1. Pharmacokinetics and tissue distribution of 2-fluoro-beta-alanine in rats. Potential relevance to toxicity pattern of 5-fluorouracil.
      R W Zhang, S J Soong, T P Liu, S Barnes and S B Diasio
      Drug Metabolism and Disposition January 1992, 20 (1) 113-119;

  4. Beers, S A

    1. Pharmacokinetic evaluation of (-)-6-aminocarbovir as a prodrug for (-)-carbovir in rats.
      C L Zimmerman, R P Remmel, S S Ibrahim, S A Beers and R Vince
      Drug Metabolism and Disposition January 1992, 20 (1) 47-51;

  5. Beskitt, J L

    1. Pharmacokinetics of 2-ethyl-1,3-hexanediol. II. Nonsystemic disposition following single percutaneous or peroral doses in Fischer 344 rats.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant and B Ballantyne
      Drug Metabolism and Disposition January 1992, 20 (1) 6-18;

  6. Boelsterli, U A

    1. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes.
      U A Boelsterli, A Lanzotti, C Göldlin and M Oertle
      Drug Metabolism and Disposition January 1992, 20 (1) 96-101;

C

  1. Catlow, J

    1. Disposition of the novel serotonin agonist, LY228729, in monkeys and rats.
      S P Swanson and J Catlow
      Drug Metabolism and Disposition January 1992, 20 (1) 102-107;

  2. Chang, J

    1. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats.
      B S Kuo, W F Kusmik, J C Poole, S H Elsea, J Chang and K K Hwang
      Drug Metabolism and Disposition January 1992, 20 (1) 23-30;

  3. Cheriathundam, E

    1. Comparisons of hepatic and renal cytochromes P-450-dependent monooxygenases from fuzzy and Sprague-Dawley rats.
      E Cheriathundam, R Almirez and A P Alvares
      Drug Metabolism and Disposition January 1992, 20 (1) 19-22;

  4. Coon, M J

    1. Substituted pyridines: nonsteroidal inhibitors of human placental aromatase cytochrome P-450.
      A D Vaz, M J Coon, H Peegel and K M Menon
      Drug Metabolism and Disposition January 1992, 20 (1) 108-112;

  5. Coutant, J E

    1. Metabolism of the anticoagulant peptide, MDL 28,050, in rats.
      M P Knadler, B L Ackermann, J E Coutant and G H Hurst
      Drug Metabolism and Disposition January 1992, 20 (1) 89-95;

D

  1. Damani, L A

    1. The urinary metabolic profile of metyrapone in the rat. Identification of two novel isomeric metyrapol N-oxide metabolites.
      J I Usansky and L A Damani
      Drug Metabolism and Disposition January 1992, 20 (1) 64-69;

  2. Davis, P J

    1. Microbial models of mammalian metabolism. Biotransformations of N-methylcarbazole using the fungus Cunninghamella echinulata.
      W Yang and P J Davis
      Drug Metabolism and Disposition January 1992, 20 (1) 38-46;

  3. Diasio, S B

    1. Pharmacokinetics and tissue distribution of 2-fluoro-beta-alanine in rats. Potential relevance to toxicity pattern of 5-fluorouracil.
      R W Zhang, S J Soong, T P Liu, S Barnes and S B Diasio
      Drug Metabolism and Disposition January 1992, 20 (1) 113-119;

  4. Digenis, G A

    1. Isolation and identification of the major urinary metabolite of N-methylpyrrolidinone in the rat.
      D A Wells, A A Hawi and G A Digenis
      Drug Metabolism and Disposition January 1992, 20 (1) 124-126;

E

  1. Elsea, S H

    1. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats.
      B S Kuo, W F Kusmik, J C Poole, S H Elsea, J Chang and K K Hwang
      Drug Metabolism and Disposition January 1992, 20 (1) 23-30;

F

  1. Frantz, S W

    1. Pharmacokinetics of 2-ethyl-1,3-hexanediol. II. Nonsystemic disposition following single percutaneous or peroral doses in Fischer 344 rats.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant and B Ballantyne
      Drug Metabolism and Disposition January 1992, 20 (1) 6-18;

  2. Funae, Y

    1. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta 9-tetrahydrocannabinol by liver microsomes of adult female rats.
      S Narimatsu, K Watanabe, T Matsunaga, I Yamamoto, S Imaoka, Y Funae and H Yoshimura
      Drug Metabolism and Disposition January 1992, 20 (1) 79-83;

G

  1. Göldlin, C

    1. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes.
      U A Boelsterli, A Lanzotti, C Göldlin and M Oertle
      Drug Metabolism and Disposition January 1992, 20 (1) 96-101;

  2. Grosse, C M

    1. Pharmacokinetics of 2-ethyl-1,3-hexanediol. II. Nonsystemic disposition following single percutaneous or peroral doses in Fischer 344 rats.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant and B Ballantyne
      Drug Metabolism and Disposition January 1992, 20 (1) 6-18;

  3. Guzelian, P S

    1. Characterization of human liver cytochromes P-450 involved in theophylline metabolism.
      M A Sarkar, C Hunt, P S Guzelian and H T Karnes
      Drug Metabolism and Disposition January 1992, 20 (1) 31-37;

H

  1. Hawi, A A

    1. Isolation and identification of the major urinary metabolite of N-methylpyrrolidinone in the rat.
      D A Wells, A A Hawi and G A Digenis
      Drug Metabolism and Disposition January 1992, 20 (1) 124-126;

  2. Hunt, C

    1. Characterization of human liver cytochromes P-450 involved in theophylline metabolism.
      M A Sarkar, C Hunt, P S Guzelian and H T Karnes
      Drug Metabolism and Disposition January 1992, 20 (1) 31-37;

  3. Hurst, G H

    1. Metabolism of the anticoagulant peptide, MDL 28,050, in rats.
      M P Knadler, B L Ackermann, J E Coutant and G H Hurst
      Drug Metabolism and Disposition January 1992, 20 (1) 89-95;

  4. Hwang, K K

    1. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats.
      B S Kuo, W F Kusmik, J C Poole, S H Elsea, J Chang and K K Hwang
      Drug Metabolism and Disposition January 1992, 20 (1) 23-30;

I

  1. Ibrahim, S S

    1. Pharmacokinetic evaluation of (-)-6-aminocarbovir as a prodrug for (-)-carbovir in rats.
      C L Zimmerman, R P Remmel, S S Ibrahim, S A Beers and R Vince
      Drug Metabolism and Disposition January 1992, 20 (1) 47-51;

  2. Imaoka, S

    1. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta 9-tetrahydrocannabinol by liver microsomes of adult female rats.
      S Narimatsu, K Watanabe, T Matsunaga, I Yamamoto, S Imaoka, Y Funae and H Yoshimura
      Drug Metabolism and Disposition January 1992, 20 (1) 79-83;

  3. Inaba, T

    1. Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6).
      S V Otton, R F Tyndale, D Wu, T Inaba, W Kalow and E M Sellers
      Drug Metabolism and Disposition January 1992, 20 (1) 1-5;

K

  1. Kalow, W

    1. Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6).
      S V Otton, R F Tyndale, D Wu, T Inaba, W Kalow and E M Sellers
      Drug Metabolism and Disposition January 1992, 20 (1) 1-5;

  2. Karnes, H T

    1. Characterization of human liver cytochromes P-450 involved in theophylline metabolism.
      M A Sarkar, C Hunt, P S Guzelian and H T Karnes
      Drug Metabolism and Disposition January 1992, 20 (1) 31-37;

  3. Knadler, M P

    1. Metabolism of the anticoagulant peptide, MDL 28,050, in rats.
      M P Knadler, B L Ackermann, J E Coutant and G H Hurst
      Drug Metabolism and Disposition January 1992, 20 (1) 89-95;

  4. Kucharczyk, N

    1. Felbamate metabolism in pediatric and adult beagle dogs.
      J T Yang, M Morris, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition January 1992, 20 (1) 84-88;

  5. Kuo, B S

    1. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats.
      B S Kuo, W F Kusmik, J C Poole, S H Elsea, J Chang and K K Hwang
      Drug Metabolism and Disposition January 1992, 20 (1) 23-30;

  6. Kuroiwa, Y

    1. Deacetylation of cinobufagin by rat liver.
      L Zhang, K Aoki, T Yoshida and Y Kuroiwa
      Drug Metabolism and Disposition January 1992, 20 (1) 52-55;

  7. Kusmik, W F

    1. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats.
      B S Kuo, W F Kusmik, J C Poole, S H Elsea, J Chang and K K Hwang
      Drug Metabolism and Disposition January 1992, 20 (1) 23-30;

L

  1. Ladona, M

    1. Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans.
      S E Ball, G Maurer, M Zollinger, M Ladona and A E Vickers
      Drug Metabolism and Disposition January 1992, 20 (1) 56-63;

  2. Lanzotti, A

    1. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes.
      U A Boelsterli, A Lanzotti, C Göldlin and M Oertle
      Drug Metabolism and Disposition January 1992, 20 (1) 96-101;

  3. Liu, T P

    1. Pharmacokinetics and tissue distribution of 2-fluoro-beta-alanine in rats. Potential relevance to toxicity pattern of 5-fluorouracil.
      R W Zhang, S J Soong, T P Liu, S Barnes and S B Diasio
      Drug Metabolism and Disposition January 1992, 20 (1) 113-119;

M

  1. Matsunaga, T

    1. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta 9-tetrahydrocannabinol by liver microsomes of adult female rats.
      S Narimatsu, K Watanabe, T Matsunaga, I Yamamoto, S Imaoka, Y Funae and H Yoshimura
      Drug Metabolism and Disposition January 1992, 20 (1) 79-83;

  2. Maurer, G

    1. Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans.
      S E Ball, G Maurer, M Zollinger, M Ladona and A E Vickers
      Drug Metabolism and Disposition January 1992, 20 (1) 56-63;

  3. Menon, K M

    1. Substituted pyridines: nonsteroidal inhibitors of human placental aromatase cytochrome P-450.
      A D Vaz, M J Coon, H Peegel and K M Menon
      Drug Metabolism and Disposition January 1992, 20 (1) 108-112;

  4. Morris, M

    1. Felbamate metabolism in pediatric and adult beagle dogs.
      J T Yang, M Morris, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition January 1992, 20 (1) 84-88;

N

  1. Narimatsu, S

    1. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta 9-tetrahydrocannabinol by liver microsomes of adult female rats.
      S Narimatsu, K Watanabe, T Matsunaga, I Yamamoto, S Imaoka, Y Funae and H Yoshimura
      Drug Metabolism and Disposition January 1992, 20 (1) 79-83;

O

  1. Oertle, M

    1. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes.
      U A Boelsterli, A Lanzotti, C Göldlin and M Oertle
      Drug Metabolism and Disposition January 1992, 20 (1) 96-101;

  2. Otton, S V

    1. Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6).
      S V Otton, R F Tyndale, D Wu, T Inaba, W Kalow and E M Sellers
      Drug Metabolism and Disposition January 1992, 20 (1) 1-5;

P

  1. Peegel, H

    1. Substituted pyridines: nonsteroidal inhibitors of human placental aromatase cytochrome P-450.
      A D Vaz, M J Coon, H Peegel and K M Menon
      Drug Metabolism and Disposition January 1992, 20 (1) 108-112;

  2. Plakas, S M

    1. Disposition of 1-naphthol in the channel catfish (Ictalurus punctatus).
      G R Stehly and S M Plakas
      Drug Metabolism and Disposition January 1992, 20 (1) 70-73;

  3. Poole, J C

    1. Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats.
      B S Kuo, W F Kusmik, J C Poole, S H Elsea, J Chang and K K Hwang
      Drug Metabolism and Disposition January 1992, 20 (1) 23-30;

R

  1. Remmel, R P

    1. Pharmacokinetic evaluation of (-)-6-aminocarbovir as a prodrug for (-)-carbovir in rats.
      C L Zimmerman, R P Remmel, S S Ibrahim, S A Beers and R Vince
      Drug Metabolism and Disposition January 1992, 20 (1) 47-51;

S

  1. Sakai, T

    1. Metabolism of enflurane in dogs.
      T Sakai, M Takaori and H Yoshida
      Drug Metabolism and Disposition January 1992, 20 (1) 127-129;

  2. Sarkar, M A

    1. Characterization of human liver cytochromes P-450 involved in theophylline metabolism.
      M A Sarkar, C Hunt, P S Guzelian and H T Karnes
      Drug Metabolism and Disposition January 1992, 20 (1) 31-37;

  3. Schaefer, W H

    1. Formation of a carbamoyl glucuronide conjugate of carvedilol in vitro using dog and rat liver microsomes.
      W H Schaefer
      Drug Metabolism and Disposition January 1992, 20 (1) 130-133;

  4. Sellers, E M

    1. Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6).
      S V Otton, R F Tyndale, D Wu, T Inaba, W Kalow and E M Sellers
      Drug Metabolism and Disposition January 1992, 20 (1) 1-5;

  5. Sladek, N E

    1. Substrate specificity and other characteristics of a novel aldehyde dehydrogenase present in female DBA/2 mouse liver.
      N S Zhoo and N E Sladek
      Drug Metabolism and Disposition January 1992, 20 (1) 134-136;

  6. Sofia, R D

    1. Felbamate metabolism in pediatric and adult beagle dogs.
      J T Yang, M Morris, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition January 1992, 20 (1) 84-88;

  7. Sokoluk, B

    1. Comparative metabolism and covalent binding of procainamide by human leukocytes.
      J Uetrecht and B Sokoluk
      Drug Metabolism and Disposition January 1992, 20 (1) 120-123;

  8. Soong, S J

    1. Pharmacokinetics and tissue distribution of 2-fluoro-beta-alanine in rats. Potential relevance to toxicity pattern of 5-fluorouracil.
      R W Zhang, S J Soong, T P Liu, S Barnes and S B Diasio
      Drug Metabolism and Disposition January 1992, 20 (1) 113-119;

  9. Stehly, G R

    1. Disposition of 1-naphthol in the channel catfish (Ictalurus punctatus).
      G R Stehly and S M Plakas
      Drug Metabolism and Disposition January 1992, 20 (1) 70-73;

  10. Svensson, C K

    1. Effect of H2-receptor antagonists on rat liver cytosolic acetyl CoA:arylamine N-acetyltransferase activity.
      C K Svensson and M Tomilo
      Drug Metabolism and Disposition January 1992, 20 (1) 74-78;

  11. Swanson, S P

    1. Disposition of the novel serotonin agonist, LY228729, in monkeys and rats.
      S P Swanson and J Catlow
      Drug Metabolism and Disposition January 1992, 20 (1) 102-107;

T

  1. Takaori, M

    1. Metabolism of enflurane in dogs.
      T Sakai, M Takaori and H Yoshida
      Drug Metabolism and Disposition January 1992, 20 (1) 127-129;

  2. Tallant, M J

    1. Pharmacokinetics of 2-ethyl-1,3-hexanediol. II. Nonsystemic disposition following single percutaneous or peroral doses in Fischer 344 rats.
      S W Frantz, J L Beskitt, C M Grosse, M J Tallant and B Ballantyne
      Drug Metabolism and Disposition January 1992, 20 (1) 6-18;

  3. Tomilo, M

    1. Effect of H2-receptor antagonists on rat liver cytosolic acetyl CoA:arylamine N-acetyltransferase activity.
      C K Svensson and M Tomilo
      Drug Metabolism and Disposition January 1992, 20 (1) 74-78;

  4. Tyndale, R F

    1. Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6).
      S V Otton, R F Tyndale, D Wu, T Inaba, W Kalow and E M Sellers
      Drug Metabolism and Disposition January 1992, 20 (1) 1-5;

U

  1. Uetrecht, J

    1. Comparative metabolism and covalent binding of procainamide by human leukocytes.
      J Uetrecht and B Sokoluk
      Drug Metabolism and Disposition January 1992, 20 (1) 120-123;

  2. Usansky, J I

    1. The urinary metabolic profile of metyrapone in the rat. Identification of two novel isomeric metyrapol N-oxide metabolites.
      J I Usansky and L A Damani
      Drug Metabolism and Disposition January 1992, 20 (1) 64-69;

V

  1. Vaz, A D

    1. Substituted pyridines: nonsteroidal inhibitors of human placental aromatase cytochrome P-450.
      A D Vaz, M J Coon, H Peegel and K M Menon
      Drug Metabolism and Disposition January 1992, 20 (1) 108-112;

  2. Vickers, A E

    1. Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans.
      S E Ball, G Maurer, M Zollinger, M Ladona and A E Vickers
      Drug Metabolism and Disposition January 1992, 20 (1) 56-63;

  3. Vince, R

    1. Pharmacokinetic evaluation of (-)-6-aminocarbovir as a prodrug for (-)-carbovir in rats.
      C L Zimmerman, R P Remmel, S S Ibrahim, S A Beers and R Vince
      Drug Metabolism and Disposition January 1992, 20 (1) 47-51;

W

  1. Watanabe, K

    1. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta 9-tetrahydrocannabinol by liver microsomes of adult female rats.
      S Narimatsu, K Watanabe, T Matsunaga, I Yamamoto, S Imaoka, Y Funae and H Yoshimura
      Drug Metabolism and Disposition January 1992, 20 (1) 79-83;

  2. Wells, D A

    1. Isolation and identification of the major urinary metabolite of N-methylpyrrolidinone in the rat.
      D A Wells, A A Hawi and G A Digenis
      Drug Metabolism and Disposition January 1992, 20 (1) 124-126;

  3. Wong, K K

    1. Felbamate metabolism in pediatric and adult beagle dogs.
      J T Yang, M Morris, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition January 1992, 20 (1) 84-88;

  4. Wu, D

    1. Catalytic and immunologic similarities between monkey and human liver cytochrome P-450db1 (human cytochrome P-450 2D6).
      S V Otton, R F Tyndale, D Wu, T Inaba, W Kalow and E M Sellers
      Drug Metabolism and Disposition January 1992, 20 (1) 1-5;

Y

  1. Yamamoto, I

    1. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta 9-tetrahydrocannabinol by liver microsomes of adult female rats.
      S Narimatsu, K Watanabe, T Matsunaga, I Yamamoto, S Imaoka, Y Funae and H Yoshimura
      Drug Metabolism and Disposition January 1992, 20 (1) 79-83;

  2. Yang, J T

    1. Felbamate metabolism in pediatric and adult beagle dogs.
      J T Yang, M Morris, K K Wong, N Kucharczyk and R D Sofia
      Drug Metabolism and Disposition January 1992, 20 (1) 84-88;

  3. Yang, W

    1. Microbial models of mammalian metabolism. Biotransformations of N-methylcarbazole using the fungus Cunninghamella echinulata.
      W Yang and P J Davis
      Drug Metabolism and Disposition January 1992, 20 (1) 38-46;

  4. Yoshida, H

    1. Metabolism of enflurane in dogs.
      T Sakai, M Takaori and H Yoshida
      Drug Metabolism and Disposition January 1992, 20 (1) 127-129;

  5. Yoshida, T

    1. Deacetylation of cinobufagin by rat liver.
      L Zhang, K Aoki, T Yoshida and Y Kuroiwa
      Drug Metabolism and Disposition January 1992, 20 (1) 52-55;

  6. Yoshimura, H

    1. Cytochrome P-450 isozymes involved in the oxidative metabolism of delta 9-tetrahydrocannabinol by liver microsomes of adult female rats.
      S Narimatsu, K Watanabe, T Matsunaga, I Yamamoto, S Imaoka, Y Funae and H Yoshimura
      Drug Metabolism and Disposition January 1992, 20 (1) 79-83;

Z

  1. Zhang, L

    1. Deacetylation of cinobufagin by rat liver.
      L Zhang, K Aoki, T Yoshida and Y Kuroiwa
      Drug Metabolism and Disposition January 1992, 20 (1) 52-55;

  2. Zhang, R W

    1. Pharmacokinetics and tissue distribution of 2-fluoro-beta-alanine in rats. Potential relevance to toxicity pattern of 5-fluorouracil.
      R W Zhang, S J Soong, T P Liu, S Barnes and S B Diasio
      Drug Metabolism and Disposition January 1992, 20 (1) 113-119;

  3. Zhoo, N S

    1. Substrate specificity and other characteristics of a novel aldehyde dehydrogenase present in female DBA/2 mouse liver.
      N S Zhoo and N E Sladek
      Drug Metabolism and Disposition January 1992, 20 (1) 134-136;

  4. Zimmerman, C L

    1. Pharmacokinetic evaluation of (-)-6-aminocarbovir as a prodrug for (-)-carbovir in rats.
      C L Zimmerman, R P Remmel, S S Ibrahim, S A Beers and R Vince
      Drug Metabolism and Disposition January 1992, 20 (1) 47-51;

  5. Zollinger, M

    1. Characterization of the cytochrome P-450 gene family responsible for the N-dealkylation of the ergot alkaloid CQA 206-291 in humans.
      S E Ball, G Maurer, M Zollinger, M Ladona and A E Vickers
      Drug Metabolism and Disposition January 1992, 20 (1) 56-63;
Back to top

In this issue